Challenges in IPF Research
- Existing diagnostic methods struggle to differentiate IPF from other interstitial lung diseases, delaying accurate diagnoses.
- Tracking subtle changes in fibrotic progression is challenging with conventional imaging techniques, limiting understanding of disease dynamics.
- Quantifying the response to treatment in preclinical and clinical studies often requires invasive or terminal procedures.
- Current tools provide limited insight into the direct role of collagen degradation in IPF pathology and therapeutic efficacy.
- CHPs' Solution: Enable precise, non-invasive monitoring of collagen degradation to overcome these barriers and revolutionize IPF research.